Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Malaria Journal
Published in: Malaria Journal 2/2010

Open Access 01-12-2010 | Poster presentations

Ownership and utilization of LLIN after LLIN distribution campaign in a South Western state of Nigeria

Authors: Adebusola O Oyeyemi, Abdul-Gafar Alawode, Remi Sogunro

Published in: Malaria Journal | Special Issue 2/2010

Login to get access

Excerpt

Malaria is one of the leading causes of morbidity and mortality especially among children less than five years of age in malaria endemic countries including Nigeria. In order to minimize socio economic impact of malaria in the country, the Federal Ministry of Health (FMOH) and Roll Back Malaria (RBM) partners have adopted Scale Up for Impact (SUFI) approach in the revised National Malaria Strategic Plan (NMSP). As part of effort to scale up Long Lasting Insecticidal Net (LLIN) ownership and utilization in the country, the target was to increase LLIN coverage and utilization by 100% and 80% respectively in Ekiti State, one of the Southwestern States of Nigeria. …
Metadata
Title
Ownership and utilization of LLIN after LLIN distribution campaign in a South Western state of Nigeria
Authors
Adebusola O Oyeyemi
Abdul-Gafar Alawode
Remi Sogunro
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Malaria Journal / Issue Special Issue 2/2010
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-9-S2-P34

Other articles of this Special Issue 2/2010

Malaria Journal 2/2010 Go to the issue

Poster presentations

Mechanistic insights into non-immunosuppressive immunophilin ligands as potential antimalarial therapeutics

Poster presentations

Modeling the trade-off between effective case management and imported malaria cases in different settings of P. falciparum malaria transmission intensity

Oral presentation

Identification and characterization of novel Plasmodium falciparum cyclophilins and their roles in the antimalarial actions of cyclosporin A and derivatives

Oral presentation

Antimalarial activity of ulein and proof of its action on the Plasmodium falciparum digestive vacuole

Invited speaker presentation

Push-pull strategies for vector control

Oral presentation

Development of a novel drug for uncomplicated malaria targeting the mitochondrial NADH:quinone oxidoreductase
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits